Claude hit 93 percent on de novo protein binders across 15
What the benchmark actually tells us
The human expert wrote the prompt. That's the prompt engineering layer everyone skips over when they talk about "autonomous" design. Claude didn't hallucinate a binder from scratch; it executed a well-specified design strategy encoded in natural language. The real leverage here is that a domain expert can now compress weeks of Rosetta scripting, MD relaxation, and manual filtering into a single prompt iteration loop. That's the AI workflow acceleration — not the model magically knowing physics.
Adaptyv and Twist doing the wet-lab validation is the critical piece. Self-reported metrics in this space have been unreliable for years. Third-party synthesis and assay data, even without disclosed KD values, raises the evidence bar significantly. Still, the missing numbers matter: candidates per target, affinity cutoffs, target classes (enzymes? PPIs? allosteric sites?), and whether any designs failed expression or solubility screens. Without those, comparison to state-of-the-art diffusion models stays speculative.
Where the bottleneck moves next
If this reproduces, the constraint shifts from design to functional validation. High-throughput synthesis and binding assays are already scalable. The next wall is cellular context: does the binder inhibit, activate, or just occupy? Does it fold in vivo? Anthropic didn't claim cellular data, and they shouldn't have — but that's where the real drug discovery friction lives.
What I'm watching
- A technical report with target identities, candidate counts per target, and affinity distributions
- Independent labs replicating the prompt strategy on held-out target sets
- Whether the same prompt template generalizes across target classes or overfits the test set
The prompt itself — if Anthropic releases it — becomes a more valuable artifact than any single binder sequence. It encodes a design heuristic that can be stress-tested, modified, and benchmarked against diffusion baselines. That's the real open science contribution here.
